Fresenius Noninvasive Blood Pressure Validation

计划入组 159 人 · 首次发布于 2020 年 10 月 5 日

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

计划入组 42 人 · 首次发布于 2009 年 7 月 8 日

LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine

计划入组 48 人 · 首次发布于 2012 年 12 月 17 日

Pegfilgrastim(Fulphila, Fylnetra, Neulasta, Udenyca, Ziextenzo, Cegfila (previously Pegfilgrastim Mundipharma), Nyvepria, Pelgraz, Grasustek, Pelmeg, Stimufend, Dyrupeg)

SE-205

SE-170

argenx SE

Belgium

VALNEVA SE

France

CureVac SE

Germany

Analysts Maintain Buy Ratings on Fresenius SE & Co. KGaA Amid Positive Insider Sentiment

Pacira BioSciences Settles EXPAREL Patent Litigation with Fresenius Kabi, Securing Market Exclusivity Until 2030

Fresenius Kabi Launches Tyenne®, Canada's First Tocilizumab Biosimilar for Autoimmune Conditions